These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 24202206)
1. Moving forward in tackling antimicrobial resistance: WHO actions. Lusti-Narasimhan M; Pessoa-Silva CL; Temmerman M Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv57-9. PubMed ID: 24202206 [TBL] [Abstract][Full Text] [Related]
2. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Tapsall JW; Ndowa F; Lewis DA; Unemo M Expert Rev Anti Infect Ther; 2009 Sep; 7(7):821-34. PubMed ID: 19735224 [TBL] [Abstract][Full Text] [Related]
3. Gonococcal antimicrobial resistance: the implications for public health control. Ndowa FJ; Ison CA; Lusti-Narasimhan M Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872 [No Abstract] [Full Text] [Related]
4. Gonococcal antimicrobial resistance: challenges for public health control. Ndowa FJ; Ison CA; Cole MJ; Lusti-Narasimhan M Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv3-4. PubMed ID: 24243877 [No Abstract] [Full Text] [Related]
5. Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union. Unemo M; Ison CA; Cole M; Spiteri G; van de Laar M; Khotenashvili L Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv42-6. PubMed ID: 24243879 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme. Hançali A; Ndowa F; Bellaji B; Bennani A; Kettani A; Charof R; El Aouad R Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv24-7. PubMed ID: 24037141 [TBL] [Abstract][Full Text] [Related]
7. Evolving gonococcal antimicrobial resistance: research priorities and implications for management. Hook EW; Van Der Pol B Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv60-2. PubMed ID: 24243882 [TBL] [Abstract][Full Text] [Related]
8. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JR; Ramon-Pardo P; Bolan G; Wi T Sex Health; 2019 Sep; 16(5):412-425. PubMed ID: 31437420 [TBL] [Abstract][Full Text] [Related]
9. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Bala M; Kakran M; Singh V; Sood S; Ramesh V; Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv28-35. PubMed ID: 24243876 [TBL] [Abstract][Full Text] [Related]
10. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Ndowa F; Lusti-Narasimhan M; Unemo M Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629 [No Abstract] [Full Text] [Related]
11. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda. Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585 [TBL] [Abstract][Full Text] [Related]
12. Monitoring antimicrobial resistance for public health action. Tapsall JW Commun Dis Intell Q Rep; 2003; 27 Suppl():S70-4. PubMed ID: 12807278 [TBL] [Abstract][Full Text] [Related]
13. Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for Sadiq ST; Mazzaferri F; Unemo M Sex Transm Infect; 2017 Dec; 93(S4):S65-S68. PubMed ID: 28684610 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae. DonĂ V; Low N; Golparian D; Unemo M Expert Rev Mol Diagn; 2017 Sep; 17(9):845-859. PubMed ID: 28741392 [TBL] [Abstract][Full Text] [Related]
15. Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Lewis DA Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696 [TBL] [Abstract][Full Text] [Related]
16. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial. Unemo M; Shipitsyna E; Domeika M; Sex Transm Infect; 2010 Nov; 86(6):442-4. PubMed ID: 20460266 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002. Commun Dis Intell Q Rep; 2003; 27(4):488-91. PubMed ID: 15508502 [TBL] [Abstract][Full Text] [Related]
18. Gonorrhoea in 21st century--international and Polish situation. Serwin AB; Koper M; Unemo M Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630 [TBL] [Abstract][Full Text] [Related]
19. Current and future treatment options for gonorrhoea. Ison CA; Deal C; Unemo M Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv52-6. PubMed ID: 24106339 [TBL] [Abstract][Full Text] [Related]
20. The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance. Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM Sex Health; 2012 Nov; 9(5):422-9. PubMed ID: 23036167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]